DCGI nod to Serum Institute for conducting human trials of Oxford vaccine
The Drugs Controller General of India has given the Serum Institute of India a green light to conduct phase 2 and 3 human trials of the Oxford-AstraZeneca COVID-19 vaccine candidate in India